Affiliation:
1. Shanghai Eighth People’s Hospital, Shanghai, China
Funder
National Natural Science Foundation of China
Shanghai Municipal Education Commission
Publisher
Academy of Medicine, Singapore
Reference9 articles.
1. Lee MX, Peng S, Lee ARYB, et al. Clinical efficacy and long-term immunogenicity of an early triple dose regimen of SARS-CoV-2 mRNA vaccination in cancer patients. Ann Acad Med Singap 2023;52:8-16.
2. Owen DR, Allerton CMN, Anderson AS, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 2021;24;374:1586-93.
3. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. N Engl J Med 2022;386:1397-1408.
4. Najjar-Debbiny R, Gronich N, Weber G, et al. Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients. Clin Infect Dis 2023;76:e342-9.
5. Ganatra S, Dani SS, Ahmad J, et al. Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients with Coronavirus Disease 2019. Clin Infect Dis 2023;76:563-72.